Nanotech improves cystic fibrosis antibiotic by
100,000-fold

World-first nanotechnology developed by the University
of South Australia could change the lives of thousands of people
living with cystic fibrosis (CF) as shows it can improve the
effectiveness of the CF antibiotic Tobramycin, increasing its
efficacy by up to 100,000-fold.